Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1049749-92-9 | 2,5-dimethyl-4-[(morpholin-4-yl)methyl]phenyl 4-chlorobenzoate hydrochloride | AA00IP6Y | MFCD04125530
338406-75-0 | 3-(4-chlorobenzenesulfonyl)-5-(trifluoromethyl)pyridine-2-carbonitrile | AA00IP9W | MFCD00664080
866019-33-2 | 3-(1H-Pyrrol-1-yl)-3-(thiophen-3-yl)propanoic acid | AA00IPCV | MFCD00663914
400076-05-3 | 2-benzoyl-3-methyl-5-nitro-1-benzofuran | AA00IPFO | MFCD00665639
478033-42-0 | 2-[(E)-[(5-bromothiophen-2-yl)methylidene]amino]-5-phenylfuran-3-carbonitrile | AA00IPIH | MFCD01815458
303987-13-5 | (E)-[(3-nitrophenyl)methylidene]amino 2,6-difluorobenzoate | AA00IPLM | MFCD01568232
37777-63-2 | 2-(2,6-dinitrophenyl)acetic acid | AA00IPO6 | MFCD03787867
866038-90-6 | N-(3-{hydroxy[3-(trifluoromethyl)phenyl]methyl}pyridin-2-yl)-2,2-dimethylpropanamide | AA00IPR3 | MFCD03102827
672950-98-0 | 4-cyanophenyl 2-[2-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]acetate | AA00IPTT | MFCD02187461
338421-22-0 | methyl 4-(1,2,3-thiadiazol-5-yloxy)benzoate | AA00IPWQ | MFCD00202383